Inhibikase Says FDA Clears IND For IkT-001Pro To Treat Chronic Myelogenous Leukemia

RTTNews | 1041 days ago
Stocktwits
Inhibikase Says FDA Clears IND For IkT-001Pro To Treat Chronic Myelogenous Leukemia

(RTTNews) - Pharmaceutical company Inhibikase Therapeutics, Inc. (IKT) announced Friday that the U.S. Food and Drug Administration (FDA) has reviewed its Investigational New Drug (IND) application for IkT-001Pro for the treatment of Chronic Myelogenous Leukemia (CML) and issued a Study May Procced (SMP) letter.

IkT-001Pro is a prodrug formulation of imatinib mesylate and has been developed to improve the safety of the first FDA-approved Abelson (Abl) kinase inhibitor, imatinib (marketed as Gleevec).

IkT-001Pro has the potential to be a safer alternative for patients and may improve the number of patients that reach and sustain major and/or complete cytogenetic responses in stable-phase CML.

In preclinical studies, IkT-001Pro was shown to be as much as 3.4 times safer than imatinib in non-human primates, reducing burdensome gastrointestinal side effects that occur following oral administration.

Imatinib delivered as IkT-001Pro was granted Orphan Drug Designation for stable-phase CML in September, 2018.

IkT-001Pro will be evaluated in a single ascending dose bioequivalence study and will enroll approximately 64 male and female healthy volunteers aged 25 to 55 who will receive IkT-001Pro at one of four doses.

For More Such Health News, visit rttnews.com

Tags: IKT
Stocktwits
read more
Paramount To Pay $16 Mln To Settle Lawsuit By Trump Over Interview With Kamala Harris

Paramount To Pay $16 Mln To Settle Lawsuit By Trump Over Interview With Kamala Harris

Media firm Paramount Global has agreed to pay $16 million to settle a legal dispute with U.S. President Donald Trump, over its '60 Minutes' interview with former Vice President Kamala Harris, reports said. The interview was broadcast on Paramount's affiliated CBS network last year, ahead of the 2024 Presidential election.
RTTNews | 2h 17min ago
Bay Street Likely To Open With Positive Bias

Bay Street Likely To Open With Positive Bias

Canadian shares look set to open with a positive bias on Wednesday, tracking steady European markets and higher crude oil prices. Optimism about Canada and the U.S. striking a trade deal is likely to help underpin sentiment.
RTTNews | 3h 46min ago
Yen Falls Amid Risk-on Mood

Yen Falls Amid Risk-on Mood

The Japanese yen weakened against other major currencies in the European session on Wednesday amid increased risk-on mood, as investors pondered the prospect of Federal Reserve rate cuts and hoped for a positive resolution on trade discussions ahead of completion of 90-day tariff pause on July 9.
RTTNews | 4h 22min ago
FTSE 100 Up Marginally In Cautious Trade

FTSE 100 Up Marginally In Cautious Trade

The U.K. market is up marginally a little past noon on Wednesday with stock moving in a tight range as investors await fresh developments on the trade front.
RTTNews | 4h 36min ago
Yen Falls Against Majors

Yen Falls Against Majors

The Japanese yen weakened against other major currencies in the European session on Wednesday.
RTTNews | 4h 51min ago
CAC 40 Notably Higher; ArcelorMittal, LVMH Among Prominent Gainers

CAC 40 Notably Higher; ArcelorMittal, LVMH Among Prominent Gainers

French stocks are up firmly in positive territory on Wednesday, recovering well from previous session's losses. Investors are continuing to focus on the developments on the trade front ahead of the July 9 deadline for U.S.' reciprocal tariffs.
RTTNews | 5h 8min ago
German Market Up Slightly; Auto Stocks Move Higher

German Market Up Slightly; Auto Stocks Move Higher

German stocks are up in positive territory on Wednesday after back-to-back losses, with investors making some selective buying while closely watching the trade negotiations after U.S. President Donald Trump ruled out the possibility of any extension beyond the July 9 deadline for reciprocal tariffs.
RTTNews | 5h 46min ago
Tools
Economic Calendar
Market Hours
Interest Rates
Holidays Calendar
Forex Market
Forex Volatility
Forex Correlation
Forex News
forex analysis
COT Data
Liquidity
Forex Calculators
Forex Heat Map
Indicators Heatmap
Community
Community
Systems
Most Popular Systems
Strategies
Contests
Forex Charts
Forex Sentiment
Sentiment Indicator
Reviews
Brokers
Prop Trading Firms
VPS Services
Signal Providers
EA Programming Services
Affiliate Programs
PAMM Broker Services
Rebate Program Services
Trading Platforms
Expert Advisors
Crypto Exchanges
Trading Courses
Brokers
Forex Spreads
Forex Broker Quotes
Forex Broker Swaps
Forex Broker Volume
Forex Broker Promotions Press Release
Platform
Widgets
Features
API
RSS
Stock Portfolio
Affiliate Software
Advanced Charts
Support
FAQ
Help
Contact Us
Report a Bug!
About
Blog
© 2025 Myfxbook Ltd. All Rights Reserved.
HIGH RISK WARNING: Foreign exchange trading carries a high level of risk that may not be suitable for all investors. Leverage creates additional risk and loss exposure. Before you decide to trade foreign exchange, carefully consider your investment objectives, experience level, and risk tolerance. You could lose some or all of your initial investment. Do not invest money that you cannot afford to lose. Educate yourself on the risks associated with foreign exchange trading, and seek advice from an independent financial or tax advisor if you have any questions. Any data and information is provided 'as is' solely for informational purposes, and is not intended for trading purposes or advice. Past performance is not indicative of future results.